• Novo Nordisk A/S (NVO) Faces New Hurdle for Degludec More...

• Alimera Sciences (ALIM)' ILUVIEN® Receives Marketing Authorization in France for the Treatment of Chronic Diabetic Macular Edema More...

• Hemispherx Biopharma (HEB) Filing a New Drug Application in Argentina for Ampligen® to Treat Chronic Fatigue Syndrome More...

• Biogen Idec, Inc. (Massachusetts) (BIIB), Bayer AG (BAY.F) Drugs Fail to Slow MS Progression More...

• AMAG Pharmaceuticals, Inc. (AMAG) Unveils Positive Results From Iron-Deficiency Anemia Drug Feraheme More...
• Baxter International, Inc. (BAX) Alzheimer's Drug Keeps Four Patients Stable for 3 Years More...

• 23andMe, Inc. and MediGuard.org Conducting Rheumatoid Arthritis Study Sponsored by Janssen Healthcare Innovation, a Unit of Janssen Research & Development, LLC More...

• Ironwood Pharmaceuticals Files to Begin China Phase III Trial of Linaclotide More...

• Drinking Alcohol, Even in Moderation, "a Dementia Risk," Veterans Health Research Institute Study More...

• Vitamin E May Lower Liver Cancer Risk, Shanghai Jiao Tong University School of Medicine Study More...
• Vitamin B12 Supplements May Help Treat Hepatitis C, University of Naples Study More...

• Stress Fuels Breast Cancer Metastasis to Bone, Vanderbilt Center for Bone Biology Study More...

• Drug Shown to Improve Memory in Those With Down Syndrome, University of Colorado Study More...
• Galena Biopharma (RXII) Issued NeuVax™ U.S. Patent More...

• Pressure BioSciences, Inc. (BBII)' Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies More...

• Discovery Laboratories (DSCO) Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant More...

• Johnson & Johnson (JNJ) Unit Slashes 200 Jobs More...

• Innophos Holdings, Inc. Announces Acquisition of AMT Labs, Inc. for $27 Million Cash More...
• SYGNIS Pharma AG and GENETRIX Announce Proposed Combination of Businesses of SYGNIS and GENETRIX' Subsidiary X-Pol More...

• GlaxoSmithKline (GSK) Invests $18.6 Million in Amicus Therapeutics, Inc. (FOLD) to Expand Fabry Disease Drug Deal More...
• Cytomedix Inc. (CMXI) Announces Collaboration With Duke University on Phase I Clinical Study of ALD-451 in Malignant Glioma More...

• Synthon Enters Into Global License Agreement With Amgen (AMGN) and Watson Pharmaceuticals, Inc. (WPI) for Biosimilar Trastuzumab More...

• Novavax, Inc. (NVAX) and PATH Announce Partnership on RSV Vaccine More...

• Pluristem Therapeutics (PSTI) Partners With CPC Clinical Research for Peripheral Artery Disease Study More...

• Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) (ENDP) Names New President of American Medical Systems, Inc. (AMMD) More...

• Akela Pharma Inc. Announces Board of Director Transition More...
• Conatus Pharmaceuticals Inc. Appoints Daniel Ripley as Head of Corporate Development More...

• Morria Biopharmaceuticals Plc Appoints Charles Serhan Ph.D. to Scientific Advisory Board More...

• No Tears for Johnson & Johnson (JNJ), Still Remarkable More...

• Abbott Laboratories (ABT) Reports Strong Second Quarter Results More...

• 3SBio Inc. (SSRX) Schedules Unaudited Second Quarter 2012 Results3s More...

• Innospec (IOSP) Schedules Second Quarter 2012 Earnings Release and Conference Call More...

• Theravance, Inc. (THRX) to Report Second Quarter 2012 Financial Results on July 31, 2012 More...

• U.S. Charges 48 People in $500 Million Medicaid Drug Scheme More...

• Somaxon Pharmaceuticals, Inc. (SOMX) Announces Settlement of Silenor Patent Litigation With Mylan Pharmaceuticals, Inc. (MYL) and Par Pharmaceutical Companies, Inc. (PRX) More...